Table 1 Characteristics Samples of HTN With and Without VC.

From: Osteopontin regulates macrophage activation and osteoclast formation in hypertensive patients with vascular calcification

Variable

HTN-NO-VC (N = 32)

HTN-VC (N = 38)

P

Age, yrs

56.33 ± 8.97

60.64 ± 5.42

0.07

Males, %

75.0

60.5

0.2

Duration of hypertension, y

13.65 ± 11.55

21.14 ± 12.14

0.07

BMI, kg/m2

26.30 ± 4.31

26.77 ± 2.61

0.6

24 h-SBP, mm Hg

128.06 ± 12.69

135.94 ± 16.63

0.09

24 h-DBP, mm Hg

81.36 ± 8.13

78.08 ± 8.24

0.28

Glucose, mmol/L

6.05 ± 2.71

5.85 ± 0.99

0.8

LDL cholesterol, mmol/L

2.39 ± 0.57

2.86 ± 0.77

0.06

cholesterol, mmol/L

4.23 ± 0.64

4.75 ± 0.87

0.06

HDL cholesterol, mmol/L

1.06 ± ± 0.35

1.05 ± 0.22

0.9

Triglyceride, mmol/L

2.33 ± 1.21

2.32 ± 1.75

1

Creatinine, μmol/L

74.86 ± 16.25

71.25 ± 22.04

0.6

Uric acid, μmol/L

331.93 ± 76.66

366.41 ± 94.36

0.2

U-ACR, mg/mmoL

2.63 ± 1.71

2.55 ± 1.20

0.4

eGFR, ml/min•1.73 m2

98.30 ± 15.17

85.33 ± 28.01

0.1

  1. Data was shown as n(%) or mean ± SD; HTN-NO-VC: hypertensive subjects without vascular calcification; HTN-VC: hypertensive subjects with vascular calcification; S: serum; U: urine; 24 h-SBP: mean systolic blood pressure of 24-hours ambulatory blood pressure monitoring; 24 h-DBP: mean diastolic blood pressure; 24-hours ambulatory blood pressure monitoring; LDL: low density lipoprotein; HDL: high density lipoprotein; ACR: albuminecreatinine rate; eGFR: estimated glomerular filtration rate.